Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback

Why did 3M raise its profit forecast? How will Trump's GENIUS Act impact stablecoins? Why is Chevron acquiring Hess for $53 billion? What caused Block's stock to jump recently? How did Coldplay concert video affect Astronomer's CEO? Why are NPR and PBS facing $9 billion cuts? How will Trump's tariffs affect U.S. farmers?

Novartis Trims Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback

benzinga.com/markets/earnings/25/07/46465321/novartis-trims-operating-income-outlook-after-strong-q2-performance-initiates-10-billion-stock-b

Swiss pharmaceutical giant Novartis AG (NYSE:NVS) reported second-quarter 2025 earnings on Thursday and raised its full-year earnings forecast.
Quarterly sales reached $14.05 billion, almost in line with the analysts’ consensus estimate of $14.06 billion.
Net sales grew 12% year over…

This story appeared on benzinga.com, 2025-07-17 12:46:06.